Foghorn Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 04, 2023 at 07:09 am
Foghorn Therapeutics Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 29.49 million compared to USD 27.31 million a year ago. Basic loss per share from continuing operations was USD 0.7 compared to USD 0.66 a year ago.
For the six months, net loss was USD 59.98 million compared to USD 54.23 million a year ago. Basic loss per share from continuing operations was USD 1.43 compared to USD 1.31 a year ago.